Ask the clinical trials database: ClinicalTrials.gov, EU trials & PubMed
Cited answers about trial design, endpoints, comparators, status and results, drawn from the trial registries, the published literature and FDA review documents. Free, no sign-up.
Sources
What the answers draw on
Registries, journals and FDA's own review documents. Every citation opens the record it came from.
ClinicalTrials.govThe US registry of clinical studies: design, eligibility, status and posted results.
EU Clinical TrialsTrials authorised in the EU and EEA, from the Clinical Trials Information System.
PubMedMore than 40 million citations to the biomedical literature, including published trial results.
Europe PMCFull-text articles and preprints, including open-access trial reports.
FDA advisory committeesBriefing documents, votes and transcripts from FDA advisory committee meetings.
FDA CBER approvalsReview memos and approval letters for vaccines, blood products, and cell and gene therapies.
How it answers
Every claim traced to a source
Assyro Intelligence is AI, so it shows its work: check each answer against the trials and papers it cites.
- 1
Searches the sources
Each question is researched across the databases above, read at answer time or from Assyro's indexed copy.
- 2
Checks every statement
Before an answer is shown, each statement is checked against the passages it rests on. What cannot be supported is left out.
- 3
Cites what it says
Every claim carries a numbered citation that opens the source, so you can read the record yourself.
Related
Follow a trial to its FDA decision
Free Assyro databases for what happens after the data: decision dates, approvals and patents.
PDUFA calendar
Upcoming FDA decision dates for drugs and biologics.
FDA Purple Book
Licensed biologics, biosimilars and interchangeable products.
FDA Orange Book
Approved drugs with their patents and exclusivity.
Complete response letters
Why FDA did not approve an application, in its own words.
Keep going in Assyro Intelligence
Ask follow-ups, run Deep research across registries and journals, and get alerts when anything you follow changes.